BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26566627)

  • 1. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
    Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
    Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
    Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
    Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
    World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
    Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
    Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
    Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
    Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.
    Chen H; Li L; Wang S; Lei Y; Ge Q; Lv N; Zhou X; Chen C
    Oncotarget; 2014 Dec; 5(23):11873-85. PubMed ID: 25428912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
    Roy R; Dagher A; Butterfield C; Moses MA
    Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of RELM-α correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Chen P; Zhao D; Wang W; Zhang Y; Yuan Y; Wang L; Wu Y
    Oncol Rep; 2015 Jul; 34(1):77-86. PubMed ID: 25937206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR‑20b negatively regulates VEGF expression by targeting STAT3 in H22 hepatocellular carcinoma cells.
    Luo Y; He J; Tao X; Wang H; Fang Q; Guo S; Song C
    Oncol Rep; 2018 Nov; 40(5):2806-2813. PubMed ID: 30132576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.